Literature DB >> 19332698

Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy.

B Segarane1, A Li, R Paudel, S Scholz, J Neumann, A Lees, T Revesz, J Hardy, C J Mathias, N W Wood, J Holton, H Houlden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332698      PMCID: PMC2824516          DOI: 10.1212/01.wnl.0000345356.40399.eb

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

Review 1.  The role of alpha-synuclein in the pathogenesis of multiple system atrophy.

Authors:  Gregor K Wenning; Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2005-01-22       Impact factor: 17.088

2.  Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.

Authors:  O Goker-Alpan; B I Giasson; M J Eblan; J Nguyen; H I Hurtig; V M-Y Lee; J Q Trojanowski; E Sidransky
Journal:  Neurology       Date:  2006-06-21       Impact factor: 9.910

Review 3.  Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.

Authors:  D L Stone; N Tayebi; E Orvisky; B Stubblefield; V Madike; E Sidransky
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

Review 4.  Heterozygosity for a Mendelian disorder as a risk factor for complex disease.

Authors:  E Sidransky
Journal:  Clin Genet       Date:  2006-10       Impact factor: 4.438

5.  Widespread alterations of alpha-synuclein in multiple system atrophy.

Authors:  D W Dickson; W Liu; J Hardy; M Farrer; N Mehta; R Uitti; M Mark; T Zimmerman; L Golbe; J Sage; A Sima; C D'Amato; R Albin; S Gilman; S H Yen
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

6.  Glucocerebrosidase mutations in subjects with parkinsonism.

Authors:  Alicia Lwin; Eduard Orvisky; Ozlem Goker-Alpan; Mary E LaMarca; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2004-01       Impact factor: 4.797

7.  The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations.

Authors:  Tetsutaro Ozawa; Dominic Paviour; Niall P Quinn; Keith A Josephs; Hardev Sangha; Linda Kilford; Daniel G Healy; Nick W Wood; Andrew J Lees; Janice L Holton; Tamas Revesz
Journal:  Brain       Date:  2004-10-27       Impact factor: 13.501

  7 in total
  31 in total

1.  Glucocerebrosidase mutations in diffuse Lewy body disease.

Authors:  Kenya Nishioka; Owen A Ross; Carles Vilariño-Güell; Stephanie A Cobb; Jennifer M Kachergus; David M A Mann; Julie Snowden; Anna M T Richardson; David Neary; Christopher A Robinson; Alex Rajput; Spiridon Papapetropoulos; Deborah C Mash; Rajesh Pahwa; Kelly E Lyons; Zbigniew K Wszolek; Dennis W Dickson; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2011-01       Impact factor: 4.891

Review 2.  The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.

Authors:  Arash Velayati; W Haung Yu; Ellen Sidransky
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

Review 3.  GBA-Associated Parkinson's Disease and Other Synucleinopathies.

Authors:  Ziv Gan-Or; Christopher Liong; Roy N Alcalay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-08       Impact factor: 5.081

4.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Authors:  E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; E V De Marco; A Dürr; M J Eblan; S Fahn; M J Farrer; H-C Fung; Z Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; J Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; L V Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; A Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; C P Zabetian; Y Zhao; S G Ziegler
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

5.  Glucocerebrosidase mutations p.L444P and p.N370S are not associated with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration in Polish patients.

Authors:  Zygmunt Jamrozik; Agnieszka Lugowska; Jaroslaw Slawek; Hubert Kwiecinski
Journal:  J Neurol       Date:  2009-11-01       Impact factor: 4.849

Review 6.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

7.  The function of α-synuclein.

Authors:  Jacob T Bendor; Todd P Logan; Robert H Edwards
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

Review 8.  The neuropathology of genetic Parkinson's disease.

Authors:  Markos Poulopoulos; Oren A Levy; Roy N Alcalay
Journal:  Mov Disord       Date:  2012-03-26       Impact factor: 10.338

Review 9.  Genetic convergence of Parkinson's disease and lysosomal storage disorders.

Authors:  Hao Deng; Xiaofei Xiu; Joseph Jankovic
Journal:  Mol Neurobiol       Date:  2014-08-07       Impact factor: 5.590

Review 10.  The link between the GBA gene and parkinsonism.

Authors:  Ellen Sidransky; Grisel Lopez
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.